Claudia Ibarra - 07 Dec 2023 Form 4 Insider Report for DermTech, Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
11 Dec 2023, 20:02:07 UTC
Prior SEC filing
12 Sep 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jason Miller, attorney-in-fact

Key filing fact

Claudia Ibarra filed Form 4 for DermTech, Inc. on 11 Dec 2023.

Key facts

  • This page summarizes Claudia Ibarra's Form 4 filing for DermTech, Inc..
  • 5 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Dec 2023, 20:02.

Change

  • Previous filing in this sequence was filed on 12 Sep 2023.
  • Current net transaction value: -$10,140.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DMTK transaction

Common Stock

Sale

Transaction value
$219
Shares
-143
Change %
-0.07%
Price
$1.53
Shares after
200,253
Date
07 Dec 2023
Ownership
Direct
Footnotes
F1
DMTK transaction

Common Stock

Sale

Transaction value
$2,705
Shares
-1,768
Change %
-0.88%
Price
$1.53
Shares after
198,485
Date
07 Dec 2023
Ownership
Direct
Footnotes
F2
DMTK transaction

Common Stock

Sale

Transaction value
$3,060
Shares
-2,000
Change %
-1%
Price
$1.53
Shares after
196,485
Date
07 Dec 2023
Ownership
Direct
Footnotes
F3
DMTK transaction

Common Stock

Sale

Transaction value
$3,676
Shares
-2,607
Change %
-1.3%
Price
$1.41
Shares after
193,878
Date
08 Dec 2023
Ownership
Direct
Footnotes
F4
DMTK transaction

Common Stock

Sale

Transaction value
$480
Shares
-331
Change %
-0.17%
Price
$1.45
Shares after
193,547
Date
11 Dec 2023
Ownership
Direct
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 29, 2021.

Footnote F2

The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 23, 2022.

Footnote F3

The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 7, 2023.

Footnote F4

The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on January 17, 2020.

Footnote F5

The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on June 24, 2020.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .